Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China flag China · Delayed Price · Currency is CNY
14.87
+0.12 (0.81%)
Apr 15, 2026, 1:00 PM CST

SHA:600161 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,9912,6864,5553,7134,330
Cash & Short-Term Investments
1,9912,6864,5553,7134,330
Cash Growth
-25.86%-41.04%22.68%-14.25%147.68%
Accounts Receivable
2,2021,12194.131,1731,027
Other Receivables
7.613.4539.0828.3622.27
Receivables
2,2091,134133.211,2011,050
Inventory
4,0223,8692,8442,3322,144
Other Current Assets
49.5833.436.5324.8722.27
Total Current Assets
8,2727,7227,5697,2717,546
Property, Plant & Equipment
5,9065,8484,8864,0552,631
Long-Term Investments
143.2143.2146.06146.06146.06
Goodwill
572.15572.15173.92173.92127.93
Other Intangible Assets
880.47917.05686.88441.63370.99
Long-Term Deferred Tax Assets
56.4341.7746.7460.6367.01
Long-Term Deferred Charges
655.09507.82470.26552.69362.46
Other Long-Term Assets
97.76117.66208.66228.88326.85
Total Assets
16,58315,87014,18812,92911,578
Accounts Payable
81.3681.45179.169.3973.7
Accrued Expenses
153.87170.46168.69163.21150.02
Short-Term Debt
77.12----
Current Portion of Long-Term Debt
---112.99108.15
Current Portion of Leases
15.698.9617.9510.8216.51
Current Income Taxes Payable
79.51148.2161.8573.7944.86
Current Unearned Revenue
177.89213.19357.26292.72215.31
Other Current Liabilities
449.21498.07494.78434.44201.03
Total Current Liabilities
1,0351,1201,2801,157809.58
Long-Term Debt
---253.75366.25
Long-Term Leases
68.0144.8624.4225.6218.01
Long-Term Unearned Revenue
98.66107.4499.56101.992.69
Long-Term Deferred Tax Liabilities
64.2262.4428.8530.8720.14
Other Long-Term Liabilities
1.241.241.244.14.1
Total Liabilities
1,2671,3361,4341,5741,311
Common Stock
1,9771,9771,6481,6481,373
Additional Paid-In Capital
2,4632,4632,7932,7933,067
Retained Earnings
7,2956,6985,3824,3553,612
Comprehensive Income & Other
-0.1-0.1-0.1-0.1-0.1
Total Common Equity
11,73511,1399,8238,7958,052
Minority Interest
3,5813,3942,9322,5602,215
Shareholders' Equity
15,31614,53312,75411,35610,267
Total Liabilities & Equity
16,58315,87014,18812,92911,578
Total Debt
160.8253.8242.37403.17508.92
Net Cash (Debt)
1,8302,6324,5133,3103,821
Net Cash Growth
-30.46%-41.68%36.34%-13.38%303.40%
Net Cash Per Share
0.921.332.281.661.97
Filing Date Shares Outstanding
1,9771,9771,9771,9771,977
Total Common Shares Outstanding
1,9771,9771,9771,9771,977
Working Capital
7,2386,6026,2906,1136,736
Book Value Per Share
5.935.634.974.454.07
Tangible Book Value
10,2839,6508,9628,1807,553
Tangible Book Value Per Share
5.204.884.534.143.82
Buildings
2,9632,7112,2411,957963.02
Machinery
3,1222,7602,2181,9961,258
Construction In Progress
2,1772,4782,0441,5321,623
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.